| Liposomes: Advancements and innovation in the manufacturing process S Shah, V Dhawan, R Holm, MS Nagarsenker, Y Perrie Advanced Drug Delivery Reviews 154, 102-122, 2020 | 345 | 2020 |
| Cholesterol level affects surface charge of lipid membranes in saline solution A Magarkar, V Dhawan, P Kallinteri, T Viitala, M Elmowafy, T Róg, ... Scientific reports 4 (1), 5005, 2014 | 214 | 2014 |
| Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration AA Date, MS Nagarsenker, S Patere, V Dhawan, RP Gude, PA Hassan, ... Molecular Pharmaceutics 8 (3), 716-726, 2011 | 101 | 2011 |
| Catanionic systems in nanotherapeutics–Biophysical aspects and novel trends in drug delivery applications VV Dhawan, MS Nagarsenker Journal of Controlled Release 266, 331-345, 2017 | 55 | 2017 |
| Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation AS Jain, PN Goel, SM Shah, VV Dhawan, Y Nikam, RP Gude, ... Biomedicine & pharmacotherapy 68 (4), 429-438, 2014 | 54 | 2014 |
| Cationic nanoemulsions as potential carriers for intracellular delivery PV Khachane, AS Jain, VV Dhawan, GV Joshi, AA Date, R Mulherkar, ... Saudi Pharmaceutical Journal 23 (2), 188-194, 2015 | 44 | 2015 |
| Bolaamphiphiles: a pharmaceutical review M Fariya, A Jain, V Dhawan, S Shah, MS Nagarsenker Advanced Pharmaceutical Bulletin 4 (Suppl 2), 483, 2014 | 44 | 2014 |
| Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: Synthesis, characterization, and proof of concept of hepatospecific delivery PO Pathak, MS Nagarsenker, CR Barhate, SG Padhye, VV Dhawan, ... Carbohydrate research 408, 33-43, 2015 | 37 | 2015 |
| Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in … P Pathak, V Dhawan, A Magarkar, R Danne, S Govindarajan, S Ghosh, ... International Journal of Pharmaceutics 509 (1-2), 149-158, 2016 | 32 | 2016 |
| In Vitro and Ex Vivo Evaluations of Lipid Anti-Cancer Nanoformulations: Insights and Assessment of Bioavailability Enhancement AS Jain, VV Dhawan, B Sarmento, MS Nagarsenker AAPS PharmSciTech 17, 553-571, 2016 | 23 | 2016 |
| Stearylated cycloarginine nanosystems for intracellular delivery–simulations, formulation and proof of concept V Dhawan, A Magarkar, G Joshi, D Makhija, A Jain, J Shah, BVV Reddy, ... RSC advances 6 (114), 113538-113550, 2016 | 18 | 2016 |
| Apoptosis induction and anti-cancer activity of LeciPlex formulations VV Dhawan, GV Joshi, AS Jain, YP Nikam, RP Gude, R Mulherkar, ... Cellular Oncology 37, 339-351, 2014 | 15 | 2014 |
| Lipid Architectonics for Superior Oral Bioavailability of Nelfinavir Mesylate: Comparative in vitro and in vivo Assessment T Belubbi, S Shevade, V Dhawan, V Sridhar, A Majumdar, R Nunes, ... AAPS PharmSciTech 19, 3584-3598, 2018 | 12 | 2018 |
| Nanostructured polymer scaffolds for tissue engineering technology C Fernandes, D Suares, V Dhawan, P Prabhu Fundamentals of Nanoparticles, 451-483, 2018 | 7 | 2018 |
| Lipid nanocarriers for intracellular delivery CB Fernandes, D Suares, V Dhawan Multifunctional Nanocarriers for Contemporary Healthcare Applications, 129-156, 2018 | 5 | 2018 |
| Preparation and development of nanoemulsion for skin moisturizing G Pereira, C Fernandes, V Dhawan, V Dixit Nanotechnology for the Preparation of Cosmetics Using Plant-Based Extracts …, 2022 | 4 | 2022 |
| Polysaccharide conjugates surpass monosaccharide ligands in hepatospecific targeting–Synthesis and comparative in silico and in vitro assessment V Dhawan, G Joshi, B Sutariya, J Shah, M Ashtikar, K Nagarsekar, ... Carbohydrate Research 509, 108417, 2021 | 4 | 2021 |
| Lipid nanoconstructs for superior hepatoprotection: In vitro assessments as predictive tool for in vivo translation V Dhawan, B Sutariya, A Lokras, J Thamm, M Saraf, U Warawdekar, ... International Journal of Pharmaceutics 579, 119176, 2020 | 4 | 2020 |
| Polysaccharide and monosaccharide guided liver delivery of sorafenib tosylate–a nano-strategic approach and comparative assessment of hepatospecificity V Dhawan, A Lokras, G Joshi, M Marwah, M Venkatraman, B Mohanty, ... International Journal of Pharmaceutics 625, 122039, 2022 | 3 | 2022 |
| Role of nanomedicine in hepatic targeting- deciphering strategies with molecular insights and preclinical prospects V Dhawan, M Marwah, M Nagarsenker Drug Delivery Letters, 2017 | 3 | 2017 |
Aniket MagarkarBoehringer-Ingelheim PharmaVerified email at boehringer-ingelheim.com
